B Background
• Breast Conservation Therapy (BCT), defined as local excision to remove the tumor followed by whole breast radiation therapy (WBRT), is a standard treatment option for early-stage breast cancers
• After WBRT, a common practice is delivery of a "radiation boost" directed to the tumor bed whereby an additional 4-8 fractions allow for dose-escalation to the region at highest risk for local recurrence
• The practice of 'boosting' has been demonstrated to provide a small but statistically significant reduction in IBTR risk in all age groups for invasive cancers (4% at 20 years) but robust data for DCIS specifically are lacking B Background
• Because DCIS has an excellent prognosis with very few recurrences after WBRT, demonstrating similar results specific to DCIS require large numbers of patients with very long follow up
• The purpose of this study was to create a DCIS database of patients treated with WBRT with and without a boost, to analyze the effects of the boost specifically for DCIS M Method
• An a priori power calculation was conducted to determine the number of patients needed to demonstrate a significant difference of 3% between boost and no-boost
• >2,982 patients (n boost =1,988; n no-boost =994) estimated to be required
• 10 academic institutions in the US, Canada, and France contributed de-identified patient-level data
• All patients had newly diagnosed pure DCIS (no micro-invasion), treated with breast conserving surgery and received WBRT+/-boost
• Data were uniformly re-coded at the host institution and underwent primary and secondary reviews prior to analysis
R Results
• The final cohort consisted of 4,131 DCIS patients (n boost =2,661; n noboost =1,470), exceeding the sample size estimation by 39%
• Median follow-up =9 years 
